Abstract
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) always require platelet transfusions, but the increase in platelet count is often less than expected. Since factors responsible for poor response to platelet transfusions in this clinical setting are largely unknown, we performed a prospective study in 87 consecutive children transplanted in a single institution. The mean 16-h corrected count increment (CCI) of 598 platelet transfusions was 5.76 ± 8.32 × 109/l. Both before and after HSCT, 13.8% of patients had antibodies against HLA and/or platelet-specific antigens. Univariate analysis identified 12 factors significantly associated with a lower post-transfusion CCI, but only four reached statistical significance in the multivariate analysis. These four factors were concomitant therapy with vancomycin, alloimmunization, use of an Autopheresis cell separator for preparation of platelet concentrates and cytomegalovirus infection. We, therefore, suggest that a better response to platelet transfusions could be obtained by choosing a suitable cell separator, by avoiding the use of vancomycin and by adopting measures that reduce alloimmunization and CMV infection. Moreover, screening patients for HLA and platelet-specific antibodies before HSCT would identify the majority of subjects who will develop alloimmune refractoriness after transplantation and would allow the search for a compatible donor in advance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Meehan KR, Matias CO, Rathore SS, Sandler SG, Kallich J, LaBrecque J, Erder H, Schulman KA . Platelet transfusions: utilization and associated costs in a tertiary care hospital Am J Hematol 2000 64: 251–256
Heddle NM . The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies Transfus Med Rev 1994 8: 15–28
The Trial to Reduce Alloimmunization to Platelets Study Group . Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion N Engl J Med 1997 337: 1861–1869
Ishida A, Handa M, Wakui M, Okamoto S, Kamakura M, Ikeda Y . Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation – a prospective analysis Transfusion 1998 38: 839–847
Friedberg RC, Mintz PD . Causes of refractoriness to platelet transfusion Curr Opin Hematol 1995 2: 493–498
Klumpp TR, Herman JH, Innis S, Pearlman E, Culling N, Kotz KW, Slachta C, Goldberg SL, Mangan KF . Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation Bone Marrow Transplant 1996 17: 1035–1041
Toor AA, Choo SY, Little J . Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation Bone Marrow Transplant 2000 26: 315–320
Bishop JF, McGrath K, Wolf MM, Matthews JP, De Luise T, Holdsworth R, Yuen K, Veale M, Whiteside MG, Cooper IA . Clinical factors influencing the efficacy of pooled platelet transfusions Blood 1988 71: 383–387
Alcorta I, Pereira A, Ordinas A . Clinical and laboratory factors associated with platelet transfusion refractoriness: a case-control study Br J Haematol 1996 93: 220–224
Bock M, Muggenthaler KH, Schmidt U, Heim MU . Influence of antibiotics on posttransfusion platelet increment Transfusion 1996 36: 952–954
Legler TJ, Fischer I, Dittmann J, Simson G, Lynen R, Humpe A, Riggert J, Schleyer E, Kern W, Hiddemann W, Kohler M . Frequency and causes of refractoriness in multiply transfused patients Ann Hematol 1997 74: 185–189
Doughty HA, Murphy MF, Metcalfe P, Rohatiner AZ, Lister TA, Waters AH . Relative importance of immune and non-immune causes of platelet refractoriness Vox Sang 1994 66: 200–205
Heal JM, Rowe JM, McMican A, Masel D, Finke C, Blumberg N . The role of ABO matching in platelet transfusion Eur J Haematol 1993 50: 110–117
Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V . Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia N Engl J Med 1986 314: 729–735
Balduini CL, Noris P, Giorgiani G, Martinetti M, Klersy C, Spedini P, Belletti S, Maccario R, Gusberti L, Locatelli F . Incompatibility for CD31 and human platelet antigens (HPA) and acute graft-versus-host disease after bone marrow transplantation Br J Haematol 1999 106: 723–729
Locatelli F, Pession A, Bonetti E, Maserati E, Prete L, Pedrazzoli P, Zecca M, Prete A, Paolucci P, Cazzola M . Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation inchildren with myelodysplastic syndromes Leukemia 1994 8: 844–849
Slichter SJ, Harker LA . Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood Br J Haematol 1976 34: 395–402
Pietersz RNI, Reesink HW, Dekker WJA, Fijen FJ . Preparation of leukocyte-poor platelet concentrates from buffy coat. I. Special inserts for centrifuge cups Vox Sang 1987 53: 203–207
Locatelli F, Percivalle E, Comoli P, Maccario R, Zecca M, Giorgiani G, De Stefano P, Gerna G . Human cytomegalovirus infection in pediatric patients given allogeneic bone marrow transplantation: role of early treatment of antigenemia on patients’ outcome Br J Haematol 1994 88: 64–71
Glucksberg H, Storb R, Fefer A Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Murphy MF, Water AH . Platelet transfusion: the problem of refractoriness Blood Rev 1990 4: 16–24
Slichter SJ . Platelet transfusions: a constantly evolving therapy Thromb Haemost 1991 66: 178–188
Friedman DF, Lukas MB, Jawad A, Larson PJ, Ohene-Frempong K, Manno CS . Alloimmunization to platelets in heavily transfused patients with sickle cell disease Blood 1996 88: 3216–3222
Hogge DE, McConnel M, Jacobson C, Sutherland HJ, Benny WB, Massing BG . Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients Transfusion 1995 35: 645–652
Howard CE, Adams LA, Admire JL, Chu MA, Alred GL . Vancomycin-induced thrombocytopenia: a challenge and rechallenge Ann Pharmacother 1997 31: 315–318
Govindarajan R, Baxter D, Wilson C, Zent C . Vancomycin-induced thrombocytopenia Am J Hematol 1999 62: 122–123
Kuruppu JC, Le TP, Tuazon CU . Vancomycin-associated thrombocytopenia: case report and review of the literature Am J Hematol 1999 60: 249–250
Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Nieuwenhuis HK, Lopez J, Ordinas A . Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques J Lab Clin Med 1994 124: 79–85
Chalandon Y, Mermillod B, Beris P, Doucet A, Chapuis B, Roux-Lombard P, Dayer JM . Benefit of prestorage leukocyte depletion of single-donor platelet concentrates Vox Sang 1999 76: 27–37
Verdonck LF, de Gast GC, van Heugten HG, Nieuwenhuis HK, Dekker AW . Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation Blood 1991 78: 844–848
Pamphilon DH, Rider JR, Barbara JA, Williamson LM . Prevention of transmission-transmitted cytomegalovirus infection Transfus Med 1999 9: 15–23
Novotny VM . Prevention and management of platelet transfusion refractoriness Vox Sang 1999 76: 1–13
Acknowledgements
This work was partly supported by grants from Telethon (FL and CLB), Associazione Italiana Ricerca sul Cancro (FL), Consiglio Nazionale delle Ricerche (FL), and IRCCS Policlinico S Matteo (FL and CLB).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balduini, C., Salvaneschi, L., Klersy, C. et al. Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. Leukemia 15, 1885–1891 (2001). https://doi.org/10.1038/sj.leu.2402307
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402307
Keywords
This article is cited by
-
A meta-analysis of risk factors associated with platelet transfusion refractoriness
International Journal of Hematology (2023)
-
Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
Annals of Hematology (2018)
-
Protein A column therapy for a patient refractory to platelet transfusions undergoing allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2005)